<span style="color: #222222;">A public-private partnership in India has yielded an important breakthrough, that will help produce RT PCR test kits for testing COVID 19 patients. Dr.Kiran Mazumdar Shah, the chairperson of Governing Council of National Biomedical Resource Indigenisation Consortium, NBRIC has said that two enzymes namely Taq Polymerase and Reverse Tranase needed for RT PCR test kits are developed in partnership with Bengaluru based Indian Institute of Science and private partner Richcore life sciences company. </span><br />'' <br />'' <span style="color: #222222;">She has said that Pune based Indian Institute of Science Education and Research has also partnered in the project.</span><br />'' <span style="color: #222222;"><br />'' AIR correspondent reports that India is set to locally produce RT-PCR testing and rapid antibody detection test kits for Covid-19, reducing dependence on imports. Helping this goal is the breakthrough by NBRIC in partnership with Richcore lifesciences. The two enzymes developed by them form a key to India's efforts to produce the test kits.  </span><br />'' <br />'' <span style="color: #222222;">The Chairman and Managing Director of Richcore company R Subramani has said that once these enzymes are approved and certified by cGMP, India can produce millions of test kits in a few weeks. Meanwhile in a facebook post the Primary Education minister Suresh Kumar has informed that over two lakh 19 thousand samples are tested in the state and out of which around 2100 are confirmed positive. </span>